trending Market Intelligence /marketintelligence/en/news-insights/trending/o78DV0cmvKbL1AZcPJC4zg2 content esgSubNav
Log in to other products

 /


Looking for more?

Contact Us
In This List

Sonoma Pharmaceuticals CEO, CFO depart; replacement named

Blog

Global M&A Infographic Q1 2021

Blog

Q1 2021 Global Capital Markets Activity: SPAC IPOs, Issuance in Consumer Discretionary Sector Surge

Blog

COVID-19 Impact & Recovery: Private Equity

COVID-19 Impact & Recovery: Corporates


Sonoma Pharmaceuticals CEO, CFO depart; replacement named

Sonoma Pharmaceuticals Inc. announced the departure of President and CEO Jim Schutz and CFO Bob Miller, effective Dec. 12

Schutz also resigned from the board.

The company appointed Frederick Sandford as CEO and interim CFO, effective nine months from Dec. 11, subject to a three-month mutual extension.

Sandford also joined the board as a Class III director, effective Dec. 14. He recently was president and CEO of Command Center Inc.